FAM129C | Family with sequence similarity 129, member C | Predicted intracellular proteins
| ![](/images/43277/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43277/92336_B_7_8_rna_selected_60x60.jpg) | Group enriched |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/60715/145214_A_11_11_selected_60x60.jpg) | ![](/images/2659/6600_B_9_3_rna_selected_60x60.jpg) | Group enriched |
AICDA | Activation-induced cytidine deaminase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CHRDL2 | Chordin-like 2 | Predicted intracellular proteins Predicted secreted proteins
| ![](/images/21771/ihc_selected_60x60.jpg) | ![](/images/21771/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/21771/48557_B_9_1_rna_selected_60x60.jpg) | Group enriched |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/14341/39080_B_8_5_rna_selected_60x60.jpg) | Group enriched |
FCRL3 | Fc receptor-like 3 | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| ![](/images/15508/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15508/34676_B_9_2_rna_selected_60x60.jpg) | Group enriched |
MEF2B | Myocyte enhancer factor 2B | Predicted intracellular proteins Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4734/13317_B_7_4_rna_selected_60x60.jpg) | Group enriched |
FCRLA | Fc receptor-like A | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16545/35769_B_7_6_rna_selected_60x60.jpg) | Group enriched |
IRG1 | Immunoresponsive 1 homolog (mouse) | Enzymes Predicted intracellular proteins
| ![](/images/40143/ihc_selected_60x60.jpg) | ![](/images/40143/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40143/89211_A_6_8_rna_selected_60x60.jpg) | Tissue enriched |
MCEMP1 | Mast cell-expressed membrane protein 1 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/14731/ihc_cell_selected_60x60.jpg) | ![](/images/14731/33739_B_2_5_rna_selected_60x60.jpg) | Group enriched |
BLK | BLK proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| ![](/images/5093/14004_A_6_8_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5093/14003_B_8_2_rna_selected_60x60.jpg) | Group enriched |
CCL7 | Chemokine (C-C motif) ligand 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CD19 | CD19 molecule | CD markers Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16110/36118_A_9_1_rna_selected_60x60.jpg) | Group enriched |
CLEC17A | C-type lectin domain family 17, member A | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/8928/if_selected_60x60.jpg) | | ![](/images/2624/6433_A_9_8_rna_selected_60x60.jpg) | Group enriched |
FCRL4 | Fc receptor-like 4 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| ![](/images/54030/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54030/123242_B_7_8_rna_selected_60x60.jpg) | Group enriched |
MUC4 | Mucin 4, cell surface associated | Predicted membrane proteins
| ![](/images/5895/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5895/17406_B_6_4_rna_selected_60x60.jpg) | Group enriched |
P2RX5 | Purinergic receptor P2X, ligand-gated ion channel, 5 | Predicted intracellular proteins Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/21948/50840_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CNR2 | Cannabinoid receptor 2 (macrophage) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/9719/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9719/29978_B_3_7_rna_selected_60x60.jpg) | Group enriched |
DRD5 | Dopamine receptor D5 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/48930/ihc_cell_selected_60x60.jpg) | ![](/images/48930/118540_B_9_2_rna_selected_60x60.jpg) | Group enriched |
FCRL2 | Fc receptor-like 2 | CD markers Predicted membrane proteins
| ![](/images/17619/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17619/89010_B_8_6_rna_selected_60x60.jpg) | Group enriched |
MAB21L2 | Mab-21-like 2 (C. elegans) | Disease related genes Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
TNFRSF13C | Tumor necrosis factor receptor superfamily, member 13C | CD markers Disease related genes Predicted membrane proteins
| | ![](/images/8380/if_selected_60x60.jpg) | | ![](/images/8380/19870_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CD72 | CD72 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/44658/143095_A_8_6_selected_60x60.jpg) | ![](/images/2505/6522_A_7_1_rna_selected_60x60.jpg) | Group enriched |
CEACAM4 | Carcinoembryonic antigen-related cell adhesion molecule 4 | Predicted membrane proteins
| ![](/images/12801/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/12801/30283_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CLEC4D | C-type lectin domain family 4, member D | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/4906/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4906/19765_B_7_4_rna_selected_60x60.jpg) | Group enriched |
IL24 | Interleukin 24 | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins
| ![](/images/8252/ihc_selected_60x60.jpg) | ![](/images/8252/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/8252/21432_B_7_7_rna_selected_60x60.jpg) | Group enriched |
MMP3 | Matrix metallopeptidase 3 (stromelysin 1, progelatinase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| ![](/images/7875/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7875/20325_B_8_6_rna_selected_60x60.jpg) | Group enriched |
BTLA | B and T lymphocyte associated | CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/47211/120711_A_1_7_selected_60x60.jpg) | ![](/images/62029/148777_A_5_6_rna_selected_60x60.jpg) | Group enriched |
CASP5 | Caspase 5, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| ![](/images/40937/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40937/90878_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CCR9 | Chemokine (C-C motif) receptor 9 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/6839/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/6839/16257_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CLEC5A | C-type lectin domain family 5, member A | Predicted intracellular proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CXCL13 | Chemokine (C-X-C motif) ligand 13 | Cancer-related genes Predicted secreted proteins
| ![](/images/52613/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52613/126778_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CXCL9 | Chemokine (C-X-C motif) ligand 9 | Cancer-related genes Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/1295/3239_A_3_3_rna_selected_60x60.jpg) | Group enriched |
GPR97 | G protein-coupled receptor 97 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| ![](/images/40469/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40469/88089_B_8_4_rna_selected_60x60.jpg) | Group enriched |
HLA-DOB | Major histocompatibility complex, class II, DO beta | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/13846/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13846/32452_A_9_7_rna_selected_60x60.jpg) | Group enriched |
HTR3A | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic | FDA approved drug targets Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
LTB | Lymphotoxin beta (TNF superfamily, member 3) | Cancer-related genes Plasma proteins Predicted intracellular proteins
| ![](/images/48884/ihc_selected_60x60.jpg) | ![](/images/48884/1421_G9_3_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/48884/109189_B_8_4_rna_selected_60x60.jpg) | Group enriched |
NOS2 | Nitric oxide synthase 2, inducible | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| ![](/images/2014/5433_A_4_3_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2014/5425_B_8_8_rna_selected_60x60.jpg) | Group enriched |
TLR10 | Toll-like receptor 10 | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
BANK1 | B-cell scaffold protein with ankyrin repeats 1 | Disease related genes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37002/84229_B_8_4_rna_selected_60x60.jpg) | Group enriched |
CCL19 | Chemokine (C-C motif) ligand 19 | Cancer-related genes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/3796/11202_A_9_6_rna_selected_60x60.jpg) | Group enriched |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42432/123485_A_8_2_rna_selected_60x60.jpg) | Group enriched |
FUT7 | Fucosyltransferase 7 (alpha (1,3) fucosyltransferase) | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
IL17A | Interleukin 17A | Cancer-related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| ![](/images/52258/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52258/119542_B_8_2_rna_selected_60x60.jpg) | Group enriched |
IL26 | Interleukin 26 | Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
L1TD1 | LINE-1 type transposase domain containing 1 | Predicted intracellular proteins
| ![](/images/28501/59697_A_2_7_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/30064/64713_B_1_6_rna_selected_60x60.jpg) | Group enriched |
POU2F2 | POU class 2 homeobox 2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | ![](/images_static/na_center.gif) | | ![](/images/2513/6474_A_9_5_rna_selected_60x60.jpg) | Group enriched |